Novel DNA-sensing pathway in immune response to malaria

August 4, 2011 in Medical research

Until very recently, it was unclear why infection with malaria causes fever and, under severe circumstances, an infectious death. Although the parasite has an abundance of potentially toxic molecules, no one knew which ones were responsible for the inflammatory syndrome associated with disease. Now, a new study identifies a novel DNA-sensing mechanism that plays a role in the innate immune response to the parasite that causes malaria. The findings, published online August 4th by Cell Press in the journal Immunity, provide new insight into how the immune system detects malaria and may have broad implications for treatment of multiple infectious diseases.

Malaria, the world's most common infectious disease, is caused by the falciparum. Previous studies have implicated a role for Toll-like receptor (TLR) proteins in the host's ability to sense microbial pathogens like P. falciparum. TLRs are thought to detect regions of pathogen DNA that contain repeats of cytosine and guanine bases and regulate production of the immune chemical type I interferon. However, P. falciparum DNA is made predominantly of adenine (A) and thymine (T) bases and, thus far, a role for nucleic acid sensors in malaria has not been fully explored.

"Although TLR9 has been implicated in regulating type I interferon production during in humans and mice, the unusually high A and T content in the DNA of P. falciparum prompted us to examine the possibility that malarial DNA triggers TLR9-independent DNA sensing pathways," says one of the study's senior authors, Dr. Douglas T. Golenbock from the University of Massachusetts Medical School. Dr. Golenbock and colleagues showed that the AT-rich regions of the P. falciparum genome potently induced production of type I interferons via a novel TLR9-independent pathway. The researchers went on to show that the AT-rich DNA sensing involved an unknown receptor that coupled to molecules previously linked with DNA-mediated type I interferon production.

Taken together, the results suggest that this novel AT-rich DNA sensing pathway is important in the to Plasmodial infection and may play a role in other infections as well. "As all organisms are defined by their DNA, it should not be surprising that it constitutes one of the most potent and specific immune activators," concludes study coauthor Dr. Kate Fitzgerald. "The importance of DNA recognition and type I interferon production is only now beginning to be appreciated in a large spectrum of infectious illnesses. In view of our results, as well as the emerging literature on DNA sensing, we predict that immune recognition of DNA will be an increasingly common theme in pathogenesis."

Provided by Cell Press search and more info website

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

H. pylori, smoking trends, and gastric cancer in US men

Trends in Helicobacter pylori (H. pylori) and smoking explain a significant proportion of the decline of intestinal-type noncardia gastric adenocarcinoma (NCGA) incidence in US men between 1978 and 2008, and are estimated ...

Medical research created 6 hours ago | popularity not rated yet | comments 0

Common food supplement fights degenerative brain disorders

Widely available in pharmacies and health stores, phosphatidylserine is a natural food supplement produced from beef, oysters, and soy. Proven to improve cognition and slow memory loss, it's a popular treatment for older ...

Medical research created 11 hours ago | popularity 5 / 5 (1) | comments 0 | with audio podcast

Finding a family for a pair of orphan receptors in the brain

Researchers at Emory University have identified a protein that stimulates a pair of "orphan receptors" found in the brain, solving a long-standing biological puzzle and possibly leading to future treatments for neurological ...

Medical research created 11 hours ago | popularity not rated yet | comments 0 | with audio podcast

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

Medical research created 12 hours ago | popularity 4.4 / 5 (5) | comments 0 | with audio podcast

Do men's and women's hearts burn fuel differently?

Researchers at the University of Illinois at Chicago College of Medicine will study gender differences in how the heart uses and stores fat—its main energy source—and how changes in fat metabolism play ...

Medical research created 15 hours ago | popularity not rated yet | comments 0


If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.

Drugs found to both prevent and treat Alzheimer's disease in mice

Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer's Disease in mice.